About OMICS International Conferences

Similar documents
About OMICS Group Conferences

About OMICS International Conferences

About OMICS Group. OMICS Group International is an amalgamation of Open Access acetyl-coa

About OMICS Group Conferences

About OMICS Group Conferences

About OMICS Group OMICS Group International is an amalgamation of Open Access publications and worldwide international science conferences and

About OMICS Group Conferences

About OMICS International Conferences

OMICS International Conferences

About OMICS Group Conferences

About OMICS Group Conferences

About OMICS International Conferences

About OMICS International Conferences

OMICS International Conferences

About OMICS Group Conferences

About OMICS Group Conferences

OMICS Group is an amalgamation of Open Access Publications and worldwide international science conferences and events. Established in the year 2007

About OMICS Group Conferences

About OMICS International Conferences

About OMICS Group Conferences

OMICS International Conferences

OMICS Group International is an amalgamation of Open Access publications

About OMICS Group Conferences

About OMICS Group Conferences

About OMICS Group Conferences

About OMICS Group Conferences

About OMICS Group. Prof Dr. Abdalla Omar

About OMICS International Conferences

OMICS INTERNATIONAL CONFERENCES

Pathophysiology of Lipid Disorders

About OMICS International Conferences

About OMICS Group Conferences

Basic Mechanisms of Atherosclerosis and Plaque Rupture: Clinical Implications


About OMICS Group Conferences

Lipid/Lipoprotein Structure and Metabolism (Overview)

Leptin deficiency suppresses progression of atherosclerosis in apoe-deficient mice

Potential Atheroprotective Effects of Ixmyelocel-T Cellular Therapy. Kelly J. Ledford, Nikki Murphy, Frank Zeigler, Ronnda L.

About OMICS Group. events. Established in the year 2007 with the sole aim of making the information on Sciences and technology Open Access, OMICS

Supplementary Figure S I: Effects of D4F on body weight and serum lipids in apoe -/- mice.

About OMICS Group Conferences

Role of apolipoprotein B-containing lipoproteins in the development of atherosclerosis Jan Borén MD, PhD

Inspired Functional Ingredients to Innovate and Differentiate Your Brand. Products by Ecovatec Solutions Inc.

Summary and concluding remarks

About OMICS Group Conferences

Part 1 Risk Factors and Atherosclerosis. LO1. Define the Different Forms of CVD

1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones?

Tracking a Killer Molecule

High density lipoprotein metabolism

About OMICS International Conferences

INFLUENCE OF THE HDL RECEPTOR ON ATHEROSCLEROSIS IN MICE

Lipoproteins Metabolism Reference: Campbell Biochemistry and Lippincott s Biochemistry

Dyslipidemia Endothelial dysfunction Free radicals Immunologic

Proteomics to identify novel biomarkers and therapeutic targets in cardiovascular disease

Arteriosclerosis & Atherosclerosis

About OMICS Group Conferences

Health and Disease of the Cardiovascular system

Novel Reduction of PCSK9 Expression: Mechanistic Insights into the Anti-Atherosclerotic & Hypolipidemic Effects of Heat Shock Protein 27

Complications of Diabetes mellitus. Dr Bill Young 16 March 2015

Taylor Yohe. Project Advisor: Dr. Martha A. Belury. Department of Human Nutrition at the Ohio State University

Chapter VIII: Dr. Sameh Sarray Hlaoui

CARING FOR A LOVED ONE AFTER A HEART ATTACK OR STROKE


Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins

2.5. AMPK activity

MOLECULAR MECHANISMS OF ATHEROSCLEROSIS IN THE MOUSE

Low-density lipoprotein as the key factor in atherogenesis too high, too long, or both

Cholesterol, Heart Attack and Stroke. Dr Tai E Shyong Consultant Department of Endocrinology Singapore General Hospital

The health benefits of shellfish: What should we be promoting? Professor Bruce Griffin Nutrition Division Faculty of Health & Medical Sciences

Supplementary Figure S1. Effect of Glucose on Energy Balance in WT and KHK A/C KO

Can seal oil contribute to better human health?

Histopathology: Vascular pathology

ARE YOU AT RISK OF A HEART ATTACK OR STROKE? Understand How Controlling Your Cholesterol Reduces Your Risk

Mechanisms underlying adverse effects of HDL on enos-activating pathways in patients with coronary artery disease

Key Statements. May 13, 2005

The Role of Fats. Fat provides flavour and texture to foods. Fat contributes to making us feel satiated because

MR Imaging of Atherosclerotic Plaques

ABOUT OMICS INTERNATIONAL CONFERENCES

Lipid Lowering in Patients at High Risk for Cardiovascular Disease

Child born in year /3 will die before parents in US (diabetes)

Potential mechanisms for the resolution of atherosclerosis by conjugated linoleic acid (CLA)

2.5% of all deaths globally each year. 7th leading cause of death by % of people with diabetes live in low and middle income countries

Supplemental Material. Results

Dr Rodney Itaki Lecturer Anatomical Pathology Discipline. University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology

Lipid metabolism in familial hypercholesterolemia

13/09/2012. Dietary fatty acids. Triglyceride. Phospholipids:


Nutrition & Wellness for Life 2012 Chapter 6: Fats: A Concentrated Energy Source

Pathology of Coronary Artery Disease

Quantitative Real-Time PCR was performed as same as Materials and Methods.

Nature Genetics: doi: /ng.3561

Observe the effects of atherosclerosis on the coronary artery lumen

Palm Oil: A Preferred Healthy Dietary Choice

Nutrigenetics Today s Concept Tomorrow s Reality

Nutrition, Food, and Fitness. Chapter 6 Fats: A Concentrated Energy Source

Unit IV Problem 3 Biochemistry: Cholesterol Metabolism and Lipoproteins

Non-invasive Imaging of Carotid Artery Atherosclerosis

Willem J.M. Mulder, Ph.D. Assistant Professor of Radiology Assistant Professor of Gene and Cell Medicine Director Nanomedicine Laboratory

Familial hypercholesterolaemia in children and adolescents

ESC Congress 2011 Wednesday August 31st 2011

Transcription:

About OMICS Group OMICS Group is an amalgamation of Open Access publications and worldwide international science conferences and events. Established in the year 2007 with the sole aim of making the information on Sciences and technology Open Access, OMICS Group publishes 500 online open access scholarly journals in all aspects of Science, Engineering, Management and Technology journals. OMICS Group has been instrumental in taking the knowledge on Science & technology to the doorsteps of ordinary men and women. Research Scholars, Students, Libraries, Educational Institutions, Research centers and the industry are main stakeholders that benefitted greatly from this knowledge dissemination. OMICS Group also organizes 500 International conferences annually across the globe, where knowledge transfer takes place through debates, round table discussions, poster presentations, workshops, symposia and exhibitions.

About OMICS International Conferences OMICS International is a pioneer and leading science event organizer, which publishes around 500 open access journals and conducts over 500 Medical, Clinical, Engineering, Life Sciences, Pharma scientific conferences all over the globe annually with the support of more than 1000 scientific associations and 30,000 editorial board members and 3.5 million followers to its credit. OMICS Group has organized 500 conferences, workshops and national symposiums across the major cities including San Francisco, Las Vegas, San Antonio, Omaha, Orlando, Raleigh, Santa Clara, Chicago, Philadelphia, Baltimore, United Kingdom, Valencia, Dubai, Beijing, Hyderabad, Bengaluru and Mumbai.

HDL Signaling in Macrophages and its role in atherosclerosis protection Bernardo Trigatti Department of Biochemistry and Biomedical Sciences Thrombosis and Atherosclerosis Research Institute McMaster University Hamilton, Canada 3 rd International Conference on Integrative Biology August 5, 2015, Valencia, Spain

Acknowledgements Monty Krieger Cambridge, USA Rick Austin Hamilton, Canada Suleiman Igdoura Hamilton, Canada Geoff Werstuck Hamilton, Canada Richard Lehner Edmonton, Canada Dennis Vance -- Edmonton, Canada Former members Aishah Al-Jarallah Scott Covey Omid Dadoo Kelvyn Fernades Mark Fuller Ying Pei Ali Rizvi Vivienne Tedesco David Wang Yi Zhang Current members Yazeed Alshuweishi Kristina Durham Leticia Gonzalez Melissa MacDonald Jane McBride Pei Yu Khosrow Adeli Toronto, Canada Gary Lewis Toronto, Canada Canadian Institutes of Health Research Funders Heart and Stroke Foundation of Canada

Atherosclerosis Necrotic Core Thrombus Ruptured Fibrous Cap Slide Source: Lipids Online Slide Library www.lipidsonline.org

Heart disease risk versus LDL and HDL-cholesterol levels

Low and High Density Lipoproteins LDL HDL Apolipoproteins Cholesterol Esters Triglycerides Phospholipids Cholesterol

HDL: Reverse cholesterol transport and signaling Degradation (Kidney) migration enos apoptosis HDL apoa1 ABCA1 SR-B1 ABCG1 Liver Hepatocytes blood Vascular Endothelium vascular wall Macrophage Foam Cell

Atherosclerosis Necrotic Core Thrombus Ruptured Fibrous Cap Slide Source: Lipids Online Slide Library www.lipidsonline.org

Macrophages resist ER-stress induced apoptosis 40% Annexin V TUNEL Pe ercent apoptosis Percent apoptosis 35% 30% 25% 20% 15% 10% 5% 0% 35% 30% 25% 20% 15% 10% 5% Thapsigargin Serum 0% - + Newborn Calf

Macrophages resist ER-stress induced apoptosis but become sensitive when lipoproteins are removed from serum Annexin V Pe ercent apoptosis 40% 35% 30% 25% 20% 15% 10% 5% 0% 35% TUNEL Percent apoptosis 30% 25% 20% 15% 10% 5% Thapsigargin Serum 0% - + - + Newborn Calf Newborn Calf Lipoprotein Deficient Pei Yu

HDL but not LDL suppresses ER-stress induced apoptosis in macrophages 25% Percent Ap poptosis 20% 15% 10% 5% 0% HDL (µg/ml) LDL (µg/ml) 0 0 12.5 25 50 0 0 0 0 Tunicamycin - + 0 0 12.5 25 50 Pei Yu

HDL signaling in macrophages SR-B1 HDL S1PR1 PDZK1 Gα i PI3K Akt 1 Bim Apoptosis Necrotic core Plaque instability

HDL treatment of macrophages reduces levels of the pro-apoptotic factor Bim HDL (min) 0 10 30 60 120 240 Bim β-actin Yi Zhang, Aishah Al-Jarallah

HDL mediated suppression of ER stress- induced apoptosis requires SR-B1 % Apoptoti ic Cells 60 40 20 0 Free Chol Load HDL Wild Type * * * NS - + + - - + % Apoptot tic Cells 30 20 10 0 SR-B1 KO - + + - - + Yi Zhang, Aishah Al-Jarallah

HDL is unable to suppress ER stress-induced apoptosis in the absence of PDZK1 40% Wild Type PDZK1 KO Percent Apop ptosis 30% 20% 10% 0% Tunicamycin HDL - - + + - - + + - + - + - + - + Pei Yu

S1P is required for HDL mediated protection of macrophages from apoptosis S1P Lyase Reaction S1P S1P Lyase H Fatty aldehyde Pei Yu O + Leticia Gonzalez Phosphoethanolamine Tunicamycin Apoptosis (Clea aved Caspase 3) 0.12 0.1 0.08 0.06 0.04 0.02 Control Treated HDL S1P-Lyase Treated HDL 0 - - - - + - - - + + + + - + - - - +

Knockout of S1PR1 in macrophages reduces HDL mediated protection against ER-stress induced apoptosis 35 30 Control S1PR1 KO Percent Apop ptosis 25 20 15 10 5 0 Tunicamycin HDL - + + - - + - + + - - + Leticia Gonzalez

HDL signaling in macrophages SR-B1 HDL S1PR1 PDZK1 Gα i PI3K Akt 1 Bim Apoptosis Necrotic core Plaque instability

Measurement of atherosclerosis in mice Aortic Sinus Top Cut Away 20th U.S. edition of Gray's Anatomy of the Human Body, 1918

Increased Bim immunofluorescence in atherosclerotic plaques of mice lacking SR-B1 in bone marrow derived cells Bone Marrow SR-B1 B1 +/+ SR-B1 -/- nce s) Bim Fluorescen (arbitrary units 150 100 50 0 SR-B1 * B1 +/+ SR-B1 -/- Yi Zhang, Aishah Al-Jarallah

Increased apoptosis in atherosclerotic plaques of mice lacking SR-B1 in bone marrow derived cells Bone Marrow SR-B1 B1 +/+ L 0.006 * SR-B1 -/- L Apoptotic Nuclei/µm 2 0.004 0.002 Apoptosis Nuclei 0.000 SR-B1 B1 +/+ SR-B1 -/- Yi Zhang, Aishah Al-Jarallah

Increased necrotic core size in atherosclerotic plaques of mice lacking SR-B1 in bone marrow derived cells Bone Marrow SR-B1 B1 +/+ L L % Necrotic Cor re Necrotic Core Size 0.9 0.6 0.3 * * SR-B1 -/- 0.0 SR-B1 B1 +/+ SR-B1 -/- Apoptosis Nuclei Yi Zhang, Aishah Al-Jarallah

Summary SR-B1 HDL S1PR1 Bim Apoptosis PDZK1 PI3K Gα i Thrombus Necrotic Core Ruptured Fibrous Cap Akt 1 Slide Source: Lipids Online Slide Library www.lipidsonline.org

Inactivation of SR-B1 in All Tissues of LDL Receptor -/- Mice Results in Diet-Induced Coronary Artery Atherothrombosis LDL r -/- SR-BI -/ - LDL r -/- Oil red O (Lipids) CD41 (red) Platelets 15 % Fat, 1.25 % Cholesterol, 0.5 % Cholate; 3.5 weeks Mark Fuller

SR-BI-/-LDL R-/- Mice Fed High Fat, High Cholesterol Diet Develop Extensive Cardiac Fibrosis LDL r -/- healthy SRSR-BI-/-LDL r -/- Infarcted fibrotic 15 % Fat, 1.25 % Cholesterol, 0.5 % Cholate; Cholate; 3.5 weeks; trichrome stain Mark Fuller

Reduced Survival of SR-BI -/ - LDLr -/ - mice Fed an Atherogenic Diet Survi ival 100% 75% 50% 25% LDL r -/- SR-BI -/ - LDL r -/- 0% 0 3 6 9 12 Weeks on Diet 15 % Fat, 1.25 % Cholesterol, 0.5 % Cholate Mark Fuller

Let Us Meet Again We welcome you all to our future conferences of OMICS International Please Visit: http://integrativebiology.conferenceseries.com/ http://conferenceseries.com/ http://www.conferenceseries.com/genetics-and-molecular- biology-conferences.php